2022
DOI: 10.1038/s41372-022-01377-7
|View full text |Cite
|
Sign up to set email alerts
|

Measuring quality of care in moderate and late preterm infants

Abstract: Objective To examine quality measures for moderate and late preterm (MLP) infants. Study Design By prospectively analyzing Vermont Oxford Network’s all NICU admissions database, we adapted Baby-MONITOR, a composite quality measure for extremely/very preterm infants, for MLP infants. We examined correlations between the adapted MLP quality measure (MLP-QM) in MLP infants and Baby-MONITOR in extremely and very preterm infants. Result We studied… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 38 publications
(53 reference statements)
0
8
0
Order By: Relevance
“…Additionally, inadvertent or unplanned hypothermia can be detrimental to NICU patients [31,32]. Fluid boluses and large-volume transfusions administered below physiological temperature can contribute to hypothermia.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Additionally, inadvertent or unplanned hypothermia can be detrimental to NICU patients [31,32]. Fluid boluses and large-volume transfusions administered below physiological temperature can contribute to hypothermia.…”
Section: Discussionmentioning
confidence: 99%
“…With a desire to better understand these issues in our system, we undertook the present retrospective analysis. It includes all cases of neonatal SH recorded at all Intermountain Healthcare hospitals beginning with the end-date of the previous report (July 31,2010) through March 31, 2022. Our aims were to compare the following over the past two decades; 1) the annual incidence of recognized cases of neonatal SH, 2) known fetal/neonatal and obstetrical risk factors for SH, 3) the number of transfusions, and the speci c blood components administered, to each neonate recognized to have a SH, and 4) adverse outcomes (death or neurodevelopmental impairment) among these neonates when assessed at 24 ± 6 months-old.…”
Section: Introductionmentioning
confidence: 99%
“…18,19 For MLP infants, the outcome was an MLP quality measure (MLP-QM) based on Baby-MONITOR and adapted to the MLP population. 20 Secondary outcomes were the individual components of the GA-specific quality measures. 20 The Baby-MONITOR measure consists of infant-level process measures (no admission hypothermia, no health care-associated infection, discharge on any human milk, antenatal steroid exposure, timely retinal examination), and outcome measures (survival to hospital discharge, no nonsurgically induced pneumothorax, no chronic lung disease, greater than median growth velocity).…”
Section: Outcome Variablesmentioning
confidence: 99%
“…20 Secondary outcomes were the individual components of the GA-specific quality measures. 20 The Baby-MONITOR measure consists of infant-level process measures (no admission hypothermia, no health care-associated infection, discharge on any human milk, antenatal steroid exposure, timely retinal examination), and outcome measures (survival to hospital discharge, no nonsurgically induced pneumothorax, no chronic lung disease, greater than median growth velocity). 19 The MLP-QM consists of infant-level process measures (no admission hypothermia, no health care-associated infection, discharge on any human milk) and outcome measures (survival to hospital discharge, no nonsurgically induced pneumothorax, no oxygen at 28 days of life or at discharge, change-in-weight z score, no extreme length of stay).…”
Section: Outcome Variablesmentioning
confidence: 99%
See 1 more Smart Citation